Article
Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2007
Novik Karen L, Spinelli John J, Macarthur Amy C, Shumansky Karey, Sipahimalani Payal, Leach Stephen, Lai Agnes, Connors Joseph M, Gascoyne Randy D, Gallagher Richard P, Brooks-Wilson Angela R
Abstract excerpt
Non-Hodgkin lymphoma (NHL) comprises a group of lymphoid tumors that have in common somatic translocations. H2AFX encodes a key histone involved in the detection of the DNA double-stranded breaks that can lead to translocations. H2afx is a dosage-dependent gene that protects against B-cell lympho...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
